Acm Research (ACMR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ACMR SEC filings page.
Acm Research (ACMR) reported $1.0B in revenue over the twelve months to Jun 30, 2026, up 27.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth now requires heavier reinvestment and working capital, turning previously positive cash conversion negative.
Operating cash flow swung from$152M in FY2024 to-$10M in FY2025 even as revenue rose, showing growth stopped converting into cash. The accompanying free-cash-flow reversal from$70M to-$67M points to working capital and investment absorbing the economics rather than a simple profit decline.
Revenue rose
The asset base expanded from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Acm Research's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Acm Research has an operating margin of 12.1%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is down from 19.3% the prior year.
Acm Research's revenue surged 15.2% year-over-year to $901.3M, reflecting rapid business expansion. This strong growth earns a score of 88/100.
Acm Research carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.27, Acm Research holds $3.27 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.
Acm Research's operations used $10.3M of cash, and capex of $56.3M added to the outflow, for a free cash flow shortfall of $66.6M. This results in a cash flow score of 15/100.
Acm Research's ROE of 6.4% shows moderate profitability relative to equity, earning a score of 61/100. This is down from 11.5% the prior year.
Acm Research scores 4.53, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.0B) relative to total liabilities ($941.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Acm Research passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Acm Research used $0.11 of operating cash (-$10.3M OCF vs $94.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Acm Research earns $15.73 in operating income for every $1 of interest expense ($109.4M vs $7.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Acm Research generated $292.9M in revenue in Q2 2026. This represents an increase of 36.0% from the same quarter a year earlier. Against the prior quarter it is up 26.7%.
Acm Research's EBITDA was $56.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 58.9% from the same quarter a year earlier. Against the prior quarter it is up 35.4%.
Acm Research reported $89.0M in net income in Q2 2026. This represents an increase of 199.0% from the same quarter a year earlier. Against the prior quarter it is up 414.2%.
Acm Research earned $1.23 per diluted share (EPS) in Q2 2026. This represents an increase of 179.5% from the same quarter a year earlier. Against the prior quarter it is up 412.5%.
Cash & Balance Sheet
Acm Research recorded an outflow of $71.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 19.8% from the same quarter a year earlier. Against the prior quarter it is down 38.1%.
Acm Research held $969.2M in cash against $192.9M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Acm Research's gross margin was 46.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.
Acm Research's operating margin was 17.0% in Q2 2026, reflecting core business profitability. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.
Acm Research's net profit margin was 30.4% in Q2 2026, showing the share of revenue converted to profit. This is up 16.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.9 percentage points.
Acm Research's ROE was 4.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.
Capital Allocation
Acm Research invested $42.3M in research and development in Q2 2026. This represents an increase of 24.9% from the same quarter a year earlier. Against the prior quarter it is up 15.6%.
Acm Research invested $65.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 342.0% from the same quarter a year earlier. Against the prior quarter it is up 193.3%.
Not reported for Q2 2026.
ACMR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $292.9M+36.0% | $231.3M+34.2% | $244.4M+9.4% | $269.2M+32.0% | $215.4M+6.4% | $172.3M+13.2% | $223.5M+31.2% | $204.0M+21.0% |
| Cost of Revenue | $158.3M+42.7% | $124.0M+38.1% | $144.5M+28.3% | $156.0M+57.4% | $110.9M+4.9% | $89.8M+22.9% | $112.7M+23.5% | $99.1M+23.8% |
| Gross Profit | $134.6M+28.9% | $107.2M+29.9% | $99.9M-9.8% | $113.1M+7.9% | $104.5M+7.9% | $82.5M+4.3% | $110.8M+40.1% | $104.8M+18.4% |
| R&D Expenses | $42.3M+24.9% | $36.5M+32.9% | $44.0M+58.6% | $39.7M+42.4% | $33.8M+30.2% | $27.5M+15.0% | $27.8M-14.5% | $27.8M+6.4% |
| SG&A Expenses | $18.8M+11.8% | $13.8M+6.9% | $16.7M-19.3% | $22.3M+30.6% | $16.8M+4.7% | $12.9M-18.2% | $20.7M+50.0% | $17.1M+37.7% |
| Operating Income | $49.7M+56.9% | $36.2M+40.3% | $23.0M-47.6% | $28.9M-34.5% | $31.7M-15.7% | $25.8M+2.2% | $44.0M+88.2% | $44.2M+33.2% |
| EBITDA | $56.0M+58.9% | $41.3M+46.8% | $29.1M-33.1% | $31.4M-32.6% | $35.2M-11.5% | $28.2M+1.6% | $43.5M+78.9% | $46.6M+32.3% |
| Interest Expense | $2.1M+17.2% | $1.9M+24.1% | $1.8M+45.7% | $1.9M+53.2% | $1.8M+88.5% | $1.6M+99.0% | $1.2M+76.2% | $1.2M+88.8% |
| Income Tax | $13.5M+612.4% | $3.8M+75.2% | $6.6M-62.1% | $2.7M-32.9% | $1.9M-79.7% | $2.2M-50.7% | $17.3M+113.1% | $4.0M+458.1% |
| Net Income | $89.0M+199.0% | $17.3M-15.1% | $8.0M-74.1% | $35.9M+16.1% | $29.8M+22.9% | $20.4M+16.9% | $31.1M+75.6% | $30.9M+20.3% |
| EPS (Basic) | $1.31+178.7% | $0.26-18.8% | $0.12-76.0% | $0.56+14.3% | $0.47+20.5% | $0.32+14.3% | $0.50+66.7% | $0.49+14.0% |
| EPS (Diluted) | $1.23+179.5% | $0.24-20.0% | $0.11-76.1% | $0.52+15.6% | $0.44+25.7% | $0.30+15.4% | $0.46+76.9% | $0.45+15.4% |
| Diluted Shares (Avg) | 72M+6.5% | 70M+4.2% | N/A | 68M+2.6% | 67M+0.6% | 67M+1.1% | N/A | 67M+1.9% |
ACMR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B+66.7% | $3.1B+58.5% | $2.9B+54.8% | $2.8B+54.4% | $2.0B+22.3% | $1.9B+24.2% | $1.9B+24.5% | $1.8B+27.2% |
| Current Assets | $2.9B+74.7% | $2.6B+69.2% | $2.4B+64.3% | $2.4B+63.2% | $1.6B+22.5% | $1.5B+25.9% | $1.5B+26.1% | $1.4B+29.5% |
| Cash & Equivalents | $969.2M+119.2% | $872.3M+90.8% | $757.4M+85.9% | $1.1B+217.5% | $442.1M+36.4% | $457.2M+116.4% | $407.4M+123.8% | $333.5M+61.0% |
| Short-Term Investments | $105.1M+397.7% | $34.7M+89.2% | $35.5M+83.4% | $40.0M+96.4% | $21.1M+7.7% | $18.3M-1.8% | $19.4M-9.1% | $20.4M-6.8% |
| Inventory | $783.1M+20.8% | $738.0M+21.1% | $702.6M+17.5% | $676.4M+7.6% | $648.3M+7.5% | $609.6M+131.8% | $598.0M+9.6% | $628.7M+23.9% |
| Accounts Receivable | $538.4M+24.1% | $526.5M+35.8% | $504.3M+30.3% | $477.0M+28.7% | $433.7M+47.8% | $387.8M+30.9% | $387.0M+36.7% | $370.6M+49.1% |
| Long-Term Investments | $10.7M-81.2% | $9.9M-82.0% | $9.7M+80.8% | $63.6M+88.8% | $56.7M+77.8% | $54.8M+75.2% | $5.4M-80.8% | $33.7M+50.9% |
| Total Liabilities | $994.1M+17.2% | $982.4M+26.2% | $941.7M+23.9% | $885.4M+22.1% | $848.0M+27.3% | $778.4M+30.6% | $759.8M+34.5% | $725.1M+36.3% |
| Current Liabilities | $786.3M+17.2% | $745.7M+18.6% | $745.7M+16.3% | $677.9M+11.1% | $671.0M+14.5% | $628.9M+17.9% | $641.2M+28.1% | $610.0M+26.6% |
| Non-Current Liabilities | $207.9M+17.4% | $236.7M+58.3% | $196.0M+65.3% | $207.6M+80.4% | $177.0M+121.2% | $149.5M+138.5% | $118.6M+85.0% | $115.1M+129.3% |
| Long-Term Debt | $192.9M+18.4% | $220.9M+64.2% | $178.9M+69.6% | $193.4M+82.3% | $163.0M+130.1% | $134.5M+151.9% | $105.5M+95.6% | $106.1M+166.8% |
| Total Equity | $1.9B+88.6% | $1.6B+66.6% | $1.5B+61.9% | $1.4B+61.3% | $986.5M+18.4% | $949.1M+19.2% | $904.6M+17.9% | $888.2M+21.8% |
| Retained Earnings | $456.7M+47.3% | $367.7M+31.2% | $350.4M+34.8% | $346.0M+50.9% | $310.1M+56.3% | $280.4M+60.9% | $260.0M+65.8% | $229.4M+50.6% |
Not reported in any period shown, so not listed: Goodwill.
ACMR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$6.4M+85.8% | -$29.5M-659.2% | $33.9M-61.7% | -$4.6M-138.8% | -$44.9M-172.9% | $5.3M+154.7% | $88.6M+331.0% | $11.9M+166.8% |
| Depreciation & Amortization | $6.2M+76.8% | $5.2M+116.4% | $6.0M+1308.6% | $2.5M+2.9% | $3.5M+59.2% | $2.4M-3.6% | -$500K-127.2% | $2.4M+18.1% |
| Stock-Based Compensation | $6.6M-32.6% | $5.6M-42.7% | N/A | $7.6M-36.4% | $9.8M-31.9% | $9.8M-32.6% | N/A | $11.9M+12.3% |
| Capital Expenditures | $65.1M+342.0% | $22.2M+32.7% | $13.8M+21.0% | $11.0M-66.1% | $14.7M+12.5% | $16.7M-34.2% | $11.4M-7.5% | $32.5M+16.6% |
| Free Cash Flow | -$71.5M-19.8% | -$51.7M-352.1% | $20.1M-73.9% | -$15.6M+24.2% | -$59.6M-223.0% | -$11.4M+67.4% | $77.2M+252.2% | -$20.6M+54.9% |
| Investing Cash Flow | -$69.7M-382.1% | -$9.8M+41.9% | -$347.6M-1592.8% | -$11.5M+50.7% | -$14.5M-173.8% | -$16.8M-237.0% | -$20.5M-3881.0% | -$23.3M+52.3% |
| Financing Cash Flow | $169.2M+286.6% | $163.4M+143.1% | $4.4M-71.7% | $627.1M+3240.5% | $43.8M+39.4% | $67.2M+150.3% | $15.5M+34.2% | $18.8M+421.6% |
| Share Buybacks | N/A | N/A | $0 | $0 | N/A | N/A | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
ACMR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.0%-2.5pp | 46.4%-1.5pp | 40.9%-8.7pp | 42.0%-9.4pp | 48.5%+0.7pp | 47.9%-4.1pp | 49.6%+3.2pp | 51.4%-1.1pp |
| Operating Margin | 17.0%+2.3pp | 15.6%+0.7pp | 9.4%-10.3pp | 10.8%-10.9pp | 14.7%-3.9pp | 15.0%-1.6pp | 19.7%+6.0pp | 21.7%+2.0pp |
| Net Margin | 30.4%+16.6pp | 7.5%-4.3pp | 3.3%-10.6pp | 13.3%-1.8pp | 13.8%+1.9pp | 11.8%+0.4pp | 13.9%+3.5pp | 15.2%-0.1pp |
| Return on Equity | 4.8%+1.8pp | 1.1%-1.1pp | 0.5%-2.9pp | 2.5%-1.0pp | 3.0%+0.1pp | 2.1%0.0pp | 3.4%+1.1pp | 3.5%0.0pp |
| Return on Assets | 2.6%+1.2pp | 0.6%-0.5pp | 0.3%-1.4pp | 1.3%-0.4pp | 1.5%0.0pp | 1.1%-0.1pp | 1.7%+0.5pp | 1.7%-0.1pp |
| Current Ratio | 3.66+1.2x | 3.51+1.1x | 3.27+1.0x | 3.48+1.1x | 2.45+0.2x | 2.46+0.2x | 2.310.0x | 2.37+0.1x |
| Debt-to-Equity | 0.10-0.1x | 0.140.0x | 0.120.0x | 0.140.0x | 0.17+0.1x | 0.14+0.1x | 0.120.0x | 0.12+0.1x |
| Asset Turnover | 0.090.0x | 0.080.0x | 0.090.0x | 0.100.0x | 0.110.0x | 0.090.0x | 0.120.0x | 0.110.0x |
| FCF Margin | -24.4%+3.3pp | -22.4%-15.7pp | 8.2%-26.3pp | -5.8%+4.3pp | -27.7%-51.6pp | -6.6%+16.4pp | 34.5%+64.3pp | -10.1%+17.0pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Acm Research ACMR | FY2025 | $901.3M | $94.1M | 10.4% | $5.0B | 71/100 |
| Daqo New Energy Corp DQ | FY2025 | $665.4M | -$170.5M | -25.6% | $815.4M | 33/100 |
| Veeco Instrs Inc Del VECO | FY2025 | $664.3M | $35.4M | 5.3% | $2.7B | 57/100 |
| Photronics Inc PLAB | FY2025 | $849.3M | $136.4M | 16.1% | $1.7B | 75/100 |
| Ultra Clean Hldgs Inc UCTT | FY2025 | $2.1B | -$181.2M | -8.8% | $3.4B | 48/100 |
| Kulicke & Soffa Inds Inc KLIC | FY2025 | $654.1M | $213K | 0.0% | $4.4B | 49/100 |
Where Acm Research Ranks
Frequently Asked Questions
What is Acm Research's annual revenue?
Acm Research (ACMR) reported $901.3M in total revenue for fiscal year 2025. This represents a 15.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Acm Research's revenue growing?
Acm Research (ACMR) revenue grew by 15.2% year-over-year, from $782.1M to $901.3M in fiscal year 2025.
Is Acm Research profitable?
Yes, Acm Research (ACMR) reported a net income of $94.1M in fiscal year 2025, with a net profit margin of 10.4%.
What is Acm Research's EBITDA?
Acm Research (ACMR) had EBITDA of $123.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Acm Research have?
As of fiscal year 2025, Acm Research (ACMR) had $757.4M in cash and equivalents against $178.9M in long-term debt.
What is Acm Research's gross margin?
Acm Research (ACMR) had a gross margin of 44.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Acm Research's operating margin?
Acm Research (ACMR) had an operating margin of 12.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Acm Research's net profit margin?
Acm Research (ACMR) had a net profit margin of 10.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Acm Research's return on equity (ROE)?
Acm Research (ACMR) has a return on equity of 6.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Acm Research's free cash flow?
Acm Research (ACMR) recorded an outflow of $66.6M in free cash flow during fiscal year 2025. This represents a -195.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Acm Research's operating cash flow?
Acm Research (ACMR) recorded an outflow of $10.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Acm Research's total assets?
Acm Research (ACMR) had $2.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Acm Research's capital expenditures?
Acm Research (ACMR) invested $56.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Acm Research spend on research and development?
Acm Research (ACMR) invested $145.0M in research and development during fiscal year 2025.
What is Acm Research's current ratio?
Acm Research (ACMR) had a current ratio of 3.27 as of fiscal year 2025, which is generally considered healthy.
What is Acm Research's debt-to-equity ratio?
Acm Research (ACMR) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Acm Research's return on assets (ROA)?
Acm Research (ACMR) had a return on assets of 3.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Acm Research's P/E ratio?
Acm Research (ACMR) trades at 33.6x earnings, its market capitalization divided by net income of $150.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $5.0B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Acm Research's price-to-sales ratio?
Acm Research (ACMR) trades at 4.9x sales, its market capitalization divided by revenue of $1.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $5.0B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Acm Research's Altman Z-Score?
Acm Research (ACMR) has an Altman Z-Score of 4.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Acm Research's Piotroski F-Score?
Acm Research (ACMR) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Acm Research's earnings high quality?
For every $1 of reported earnings, Acm Research (ACMR) used $0.11 of operating cash (-$10.3M OCF vs $94.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Acm Research cover its interest payments?
Acm Research (ACMR) has an interest coverage ratio of 15.73x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Acm Research?
Acm Research (ACMR) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.